Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Viome Life Sciences logo — We're on a mission to decode human biology in order to preve...

Viome Life Sciences

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.

Founded 2016 United States Bellevue, United States 30 employees Series Unknown Health Care

General Information

Company Name Viome Life Sciences
Founded Year 2016
Location United States Bellevue, United States +1
Employees 30
Industries Health Care
Funding Stage Series Unknown
Social

Get notified when Viome Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Viome Life Sciences

Viome Life Sciences, founded in 2016, is dedicated to decoding human biology to prevent and reverse chronic diseases, cancers, and aging. The company's Consumer Services (VIOME) offers a direct-to-consumer healthcare test analyzing microbial and human gene expressions utilizing proprietary technology exclusively licensed from Los Alamos National Lab. This provides individuals with health insights and personalized nutrition plans. Viome's Health Sciences division uses state-of-the-art artificial intelligence to analyze data from the world's largest gene expression database to identify root causes of diseases and develop precision therapeutics. The company's focus includes prediction, early diagnostics, prognostics, and precision therapeutics, leveraging advanced AI methods to discover biomarkers, diagnose conditions, develop companion diagnostics, and target the root cause of diseases. Viome recently received a venture round investment on 20 December 2022 from SquareOne Capital. Viome operates from the United States and aims to make illness optional through its innovative approach to personalized healthcare.

Taxonomy: genomics, microbiome analysis, precision medicine, AI in healthcare, chronic disease prevention, cancer diagnostics, aging research, molecular biology, precision therapeutics, predictive medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Unknown 1
SquareOne Capital
20 Dec 2022

FAQ About Viome Life Sciences

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.
Viome Life Sciences was founded in 2016.
Viome Life Sciences is headquartered in Bellevue, United States.
Viome Life Sciences operates in the following industries: Health Care.
Viome Life Sciences has approximately 30 employees.
Viome Life Sciences has completed 1 funding round. The latest funding stage is Series Unknown.

We're actively collecting intelligence on Viome Life Sciences.

Track Viome Life Sciences to get notified

Don't just browse. Track.

Signal Tracker monitors Viome Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy